Synthesis and Identification of Urinary Metabolites of 4-Iodo-2,5-dimethoxyphenethylamine

Journal of Forensic Sciences

Volumn 56, Issue 5, 2011, Pages 1319-1323

  Kanamori, Tatsuyuki ^a   Kuwayama, Kenji ^a   Tsujikawa, Kenji ^a   Miyaguchi, Hajime ^a   Iwata, Yuko T ^a   Inoue, Hiroyuki ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

Author keywords

Drug of abuse; Forensic science; Gas chromatography mass spectrometry; Metabolite; Rat; Synthesis; Urine

Indexed keywords

DESIGNER DRUG; HOMOVERATRYLAMINE; PSYCHOTROPIC AGENT;

ACETYLATION; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; MALE; MASS FRAGMENTOGRAPHY; METHYLATION; RAT; SPRAGUE DAWLEY RAT; URINE;

ACETYLATION; ANIMALS; DESIGNER DRUGS; DIMETHOXYPHENYLETHYLAMINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METHYLATION; MOLECULAR STRUCTURE; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79960613796     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2011.01809.x     Document Type: Article

References (11)

1. Shulgin A, Shulgin A. 2C-I; 2, 5-dimethoxy-4-iodophenethylamine. In: Joy D, editor. PiHKAL-a chemical love story. Berkeley, CA: Transform Press, 1991;539-42.
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs., 2004 (accessed July 21, 2010).
3. Habrdova V, Peters FT, Theobald DS, Maurer HH. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 2005;40:785-95.
4. Tsai CC, Liu JT, Shu YR, Chan PH, Lin CH. Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection. J Chromatogr A 2006;1101:319-23.
5. Pichini S, Pujadas M, Marchei E, Pellegrini M, Fiz J, Pacifici R, et al. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. J Pharm Biomed Anal 2008;47:335-42.
6. Wohlfarth A, Weinmann W, Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem 2010;396:2403-14.
7. Theobald DS, Pütz M, Schneider E, Maurer HH. New designer drug 4-iodo-2, 5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J Mass Spectrom 2006;41:872-86.
8. Kanamori T, Inoue H, Iwata Y, Ohmae Y, Kishi T. In vivo metabolism of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. J Anal Toxicol 2002;26:61-6.
9. Suzuki H. Direct iodination of polyalkylbenzenes: iododurene. In: Noland WE, editor. Organic synthesis, Collective Vol. 6. New York, NY: Wiley, 1988; 700.
10. Kiso Y, Ukawa K, Nakamura S, Ito K, Akita T. Efficient removal of protecting groups by a "push-pull" mechanism II. Deprotection of O-benzyltyrosine with a thioanisole-trifluoroacetic acid system without O-to-C rearrangements. Chem Pharm Bull 1980;28:673-6.
11. Kanamori T, Tsujikawa K, Ohmae Y, Iwata Y, Inoue H, Inouye Y, et al. Excretory profile of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in rat. J Health Sci 2003;49:166-9.